ATE308614T1 - Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung - Google Patents

Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung

Info

Publication number
ATE308614T1
ATE308614T1 AT97952089T AT97952089T ATE308614T1 AT E308614 T1 ATE308614 T1 AT E308614T1 AT 97952089 T AT97952089 T AT 97952089T AT 97952089 T AT97952089 T AT 97952089T AT E308614 T1 ATE308614 T1 AT E308614T1
Authority
AT
Austria
Prior art keywords
plants
derived proteins
production
recombinant collagen
collagen produced
Prior art date
Application number
AT97952089T
Other languages
English (en)
Inventor
Veronique Gruber
Jean-Yves Exposito
Florence Ruggiero
Jeanne Comte
Robert Garrone
Bertrand Merot
Philippe Bournat
Original Assignee
Meristem Therapeutics S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9499306&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE308614(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meristem Therapeutics S A filed Critical Meristem Therapeutics S A
Application granted granted Critical
Publication of ATE308614T1 publication Critical patent/ATE308614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT97952089T 1996-12-17 1997-12-17 Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung ATE308614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9616224A FR2757874B1 (fr) 1996-12-17 1996-12-17 Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
PCT/FR1997/002331 WO1998027202A1 (fr) 1996-12-17 1997-12-17 Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations

Publications (1)

Publication Number Publication Date
ATE308614T1 true ATE308614T1 (de) 2005-11-15

Family

ID=9499306

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97952089T ATE308614T1 (de) 1996-12-17 1997-12-17 Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung

Country Status (9)

Country Link
US (2) US6617431B1 (de)
EP (1) EP0951537B1 (de)
JP (1) JP2001507573A (de)
AT (1) ATE308614T1 (de)
AU (1) AU5563798A (de)
CA (1) CA2274807A1 (de)
DE (1) DE69734528T2 (de)
FR (1) FR2757874B1 (de)
WO (1) WO1998027202A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834909A1 (de) * 1998-08-03 2000-02-17 Mpb Cologne Gmbh Molecular Pla Faserproteine und ihre Herstellung
JP2003500023A (ja) 1999-04-30 2003-01-07 バイオストラタム インコーポレイテッド ラミニン８及びその使用方法
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
ATE374787T1 (de) * 1999-11-12 2007-10-15 Fibrogen Inc Rinder-kollagen und verfahren zur herstelling rekombinantes gelatin
AU2005246967B2 (en) * 1999-11-12 2008-09-04 Fibrogen, Inc. Recombinant gelatins
HK1046004B (en) * 1999-11-12 2013-11-08 Fibrogen, Inc. Recombinant gelatins
FR2807436B1 (fr) * 2000-04-10 2002-05-24 Meristem Therapeutics Methode d'obtention de fibres d'un polypeptide collagenique recombinant non-hydroxyle, et fibres de polypeptide collagenique recombinant non-hydroxyle ainsi obtenues
FR2854328B1 (fr) * 2003-04-29 2006-08-04 Rocher Yves Biolog Vegetale Composition cosmetique ou dermatologique ou pharmaceutique contenant un facteur de croissance du type vegetal de nature peptidique
US7268116B2 (en) * 2003-10-02 2007-09-11 Genhunter Corp. Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
EP2357241B1 (de) 2004-09-29 2015-03-04 Collplant Ltd. Kollagenproduzierende Pflanzen sowie Verfahren zu deren Erzeugung und Verwendung
JP2009501784A (ja) 2005-07-18 2009-01-22 プロタリクス リミテッド 生物学的に活性な高分子の粘膜投与または経腸投与
EP3015101B1 (de) 2005-10-03 2019-08-21 PINSKY, Mark A. Non-phospholipid liposomen enthaltend hyaluronsäure
US20080081353A1 (en) * 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
WO2009053985A1 (en) 2007-10-26 2009-04-30 Collplant Ltd. Methods of processing recombinant procollagen
ES2710498T3 (es) 2007-12-26 2019-04-25 Mark A Pinsky Formulaciones de colágeno para la mejora del cuidado de la piel
EP2288376B1 (de) 2008-04-18 2016-01-13 Collplant Ltd. Verfahren zur regeneration und verwendung von prokollagen
JP5737597B2 (ja) 2009-11-19 2015-06-17 浙江大学 非天然コラーゲン様タンパク質及びその応用
WO2011064773A1 (en) 2009-11-24 2011-06-03 Collplant Ltd. Method of generating collagen fibers
US9732321B2 (en) 2010-02-16 2017-08-15 The General Hospital Corporation Engineered craniofacial constructs with composite scaffold
WO2012066543A2 (en) 2010-11-16 2012-05-24 Collplant Ltd. Collagen structures and method of fabricating the same
WO2013093921A1 (en) 2011-12-20 2013-06-27 Collplant Ltd. Collagen coated synthetic polymer fibers
CA2907680A1 (en) 2013-03-21 2014-09-25 Collplant Ltd. Compositions comprising collagen and prp for tissue regeneration
EP3394095B1 (de) 2015-12-23 2023-09-27 Phoenix Tissue Repair Inc. Kollagen-7-zusammensetzungen und verfahren zur verwendung davon
US11377490B2 (en) 2017-05-31 2022-07-05 Sichuan Clover Biopharmaceuticals, Inc Method for treating cancer using disulfide-linked trimeric 4-1BBL
JP2019530757A (ja) * 2017-07-18 2019-10-24 モダン メドウ，インコーポレイテッド バイオファブリケートレザー物品、及びその方法
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
IL306070A (en) 2018-05-03 2023-11-01 Collplant Ltd Dermal fillers and their uses
GB2579036A (en) * 2018-11-15 2020-06-10 Rejuvenated Ltd Compositions comprising amino acids
TW202104254A (zh) 2019-04-12 2021-02-01 美商格爾托公司 重組彈性蛋白及其生產
FR3105792B1 (fr) 2019-12-26 2022-08-12 Michel Assor Matériau biocomposite collagène/matrice polymérique poreuse et son utilisation comme implant de réparation de lésions méniscales du genou et/ou de prévention ou de traitement de l’arthrose du genou
AU2021211721A1 (en) 2020-01-24 2022-08-18 Geltor, Inc. Animal-free dietary collagen
WO2021229577A1 (en) 2020-05-12 2021-11-18 Collplant Ltd. Collagen as a delivery tool for metal-based anti-viral agents
WO2021249011A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Hiv vaccine compositions, methods, and uses thereof
WO2021249116A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus vaccine compositions, methods, and uses thereof
WO2022041760A1 (en) 2020-08-31 2022-03-03 Sichuan Clover Biopharmaceuticals, Inc. Methods and compositions for purification of trimeric fusion proteins
EP4504761B1 (de) 2022-04-04 2026-02-04 SwiftPharma BV Rekombinante, in pflanzen produzierte und mit spinnenseidenprotein verstärkte kollagenproteine und ihre verwendung
WO2026062643A1 (en) 2024-09-20 2026-03-26 Collplant Ltd. Formulations and designs for degradable soft tissue implants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5650554A (en) * 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
WO1993007889A1 (en) * 1991-10-23 1993-04-29 Thomas Jefferson University Synthesis of human procollagens and collagens in recombinant dna systems
FR2685347A1 (fr) * 1991-12-23 1993-06-25 Univ Pasteur Procede biotechnologique d'obtention et de production microbienne d'oligomeres peptidiques comme substituts de la gelatine.
DK0636179T3 (da) * 1992-04-15 2004-12-20 Sembiosys Genetics Inc Olielegemeproteiner som bærestoffer af höjværdi-peptider i planter
US5693506A (en) * 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
US6713662B1 (en) * 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
WO1997004123A1 (en) * 1995-07-19 1997-02-06 Gel Tech Group Inc. Collagen compound production in plants
EP0939826A2 (de) * 1996-08-15 1999-09-08 Agrivax Incorporated Abgabe von tolerogenen antigenen über essbare pflanzen oder deren produkte

Also Published As

Publication number Publication date
FR2757874A1 (fr) 1998-07-03
FR2757874B1 (fr) 2003-04-25
US6617431B1 (en) 2003-09-09
JP2001507573A (ja) 2001-06-12
EP0951537B1 (de) 2005-11-02
WO1998027202A1 (fr) 1998-06-25
DE69734528D1 (de) 2005-12-08
EP0951537A1 (de) 1999-10-27
CA2274807A1 (fr) 1998-06-25
DE69734528T2 (de) 2006-07-27
AU5563798A (en) 1998-07-15
US20030096973A1 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
DE69734528D1 (de) Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung
ATE402260T1 (de) Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung
ATE355383T1 (de) Stress-gekoppeltes zellzyklus protein sowie dessen verwendung in pflanzen
DE59906898D1 (de) Alkoxysilan-endgruppen aufweisende polyurethanprepolymere, ein verfahren zu ihrer herstellung sowie ihre verwendung zur herstellung von dichtstoffen
EP1652928A4 (de) Hyaluronsäure produzierende pflanze
DE3582093D1 (de) Verfahren zur herstellung von sauerstoff als nebenprodukt bei der erzeugung von turbinenstrom.
ATE268788T1 (de) Verfahren zur herstellung von polyisocyanaten
DE69737507D1 (de) Neue nukleinsäuremoleküle aus mais und deren verwendung zur herstellung modifizierter stärke
ATE252157T1 (de) Nucleinsäuremoleküle aus pflanzen codierend enzyme, die an der stärkesynthese beteiligt sind
TR199802322T2 (xx) Apomiktik tohumunun �retimi.
ATE267260T1 (de) Verfahren zur herstellung einer osmotischen-druck-toleranten pflanze
ATE152124T1 (de) Wachstumsfaktor aus parenchymalen lebenszellen, dafür kodierendes gen, verfahren zur herstellung dieses faktors und transformanten
ATE173653T1 (de) Hydrierungskatalysator, verfahren zur herstellung dieses katalysators und seine verwendung bei der herstellung von wasserstoffperoxid
DE10348116A1 (de) CO-Generator
DE60228822D1 (de) Stress-resistenz als selektierbarer marker in transgenen pflanzen
ATE234813T1 (de) Ketonperoxidderivate, ihre herstellung und verwendung
DE68911680D1 (de) Verfahren zur herstellung von copolyarylensulfiden mit verwendung eines sauerstoffhaltigen gases.
AR008295A1 (es) Celulas inmortalizadas, y metodo para producir y usar dichas celulas para la produccion de virus.
DE69332148D1 (de) Verwendung einer dna sequenz, kodierende für ein protein mit der fäligkeit oxalsäure abzubauen, zur genselektion
ATE313632T1 (de) Durch pflanzen hergestellte rekombinante preduodenale lipase und abgeleitete polypeptide, verfahren zur herstellung und ihre verwendung
ATE72458T1 (de) Zugeordnete ribosomen und ihre verwendung zur herstellung von proteinen aus zellkulturen.
ATE373713T1 (de) Für den licht-überempfinlichkeitsphaenotyp kodierende nukleotidsequenzen von tomaten, dadurch kodierte proteine und deren verwendungen
DE50002865D1 (de) Verfahren zur herstellung von benzofuranonoximen
ATE295415T1 (de) Dna, die für einen komplement inhibitor vom schwein kodiert
ATE91502T1 (de) Verfahren zur herstellung von lignin-peroxidase durch verwendung von nichtproliferierenden phanerochaete chryosporium-zellen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties